Table 1 Demographic characteristics of 159 patients treated with greater occipital nerve injection
Total patients | n = 159 | |
|---|---|---|
Mean age (years ± SD; range) | 15 ± 2; | range 8–18 years |
Female: male (n:n); % | 108:50; | 68% - 32% |
Headache diagnosis (n; %) | ||
Chronic migraine without aura (CM) | 102 | 64% |
Chronic migraine with aura (CMwA) | 24 | 15% |
Total chronic migraine | 126 | 79% |
NDPH | 22 | 14% |
CH | 3 | 2% |
HC | 1 | 0.6% |
SUNCT/SUNA | 2 | 1% |
Total TAC | 6 | 4% |
TTH | 1 | 0.6% |
Secondary HA | 4 | 3% |
Years of headache to 1st injection (years ± SD; range) | 4.5 ± 3.2; | range 0–12 years |
Past medication (mean ± SD) | 2.1 ± 1.5 | range 0–5 |
Patients on preventive medication at time of injection (n) | 115 | |
Diagnosis of medication overuse at time of injection (n; %) | 36; | 23% |